<div class="container">

<table style="width: 100%;"><tr>
<td>Peto1980</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Aspirin after myocardial infarction example data</h2>

<h3>Description</h3>

<p>Numbers of cases (patients) and events (deaths) in
treatment and control groups of six studies.</p>


<h3>Usage</h3>

<pre><code class="language-R">data("Peto1980")</code></pre>


<h3>Format</h3>

<p>The data frame contains the following columns:
</p>

<table>
<tr>
<td style="text-align: left;">
    <b>publication</b>    </td>
<td style="text-align: left;"> <code>character</code> </td>
<td style="text-align: left;"> publication reference </td>
</tr>
<tr>
<td style="text-align: left;">
    <b>study</b>          </td>
<td style="text-align: left;"> <code>character</code> </td>
<td style="text-align: left;"> study acronym or abbreviation </td>
</tr>
<tr>
<td style="text-align: left;">
    <b>start</b>, <b>end</b> </td>
<td style="text-align: left;"> <code>integer</code>   </td>
<td style="text-align: left;"> duration of study (calendar years) </td>
</tr>
<tr>
<td style="text-align: left;">
    <b>age</b>            </td>
<td style="text-align: left;"> <code>numeric</code>   </td>
<td style="text-align: left;"> mean patient age (years) </td>
</tr>
<tr>
<td style="text-align: left;">
    <b>dose</b>           </td>
<td style="text-align: left;"> <code>numeric</code>   </td>
<td style="text-align: left;"> total daily dose (mg) </td>
</tr>
<tr>
<td style="text-align: left;">
    <b>followup</b>       </td>
<td style="text-align: left;"> <code>numeric</code>   </td>
<td style="text-align: left;"> follow-up duration (months) </td>
</tr>
<tr>
<td style="text-align: left;">
    <b>treat.cases</b>    </td>
<td style="text-align: left;"> <code>integer</code>   </td>
<td style="text-align: left;"> number of cases in treatment group </td>
</tr>
<tr>
<td style="text-align: left;">
    <b>treat.events</b>   </td>
<td style="text-align: left;"> <code>integer</code>   </td>
<td style="text-align: left;"> number of events in treatment group </td>
</tr>
<tr>
<td style="text-align: left;">
    <b>control.cases</b>  </td>
<td style="text-align: left;"> <code>integer</code>   </td>
<td style="text-align: left;"> number of cases in control group </td>
</tr>
<tr>
<td style="text-align: left;">
    <b>control.events</b> </td>
<td style="text-align: left;"> <code>integer</code>   </td>
<td style="text-align: left;"> number of events in control group </td>
</tr>
<tr>
<td style="text-align: left;">
  </td>
</tr>
</table>
<h3>Details</h3>

<p>Peto (1980) investigated mortality data from six randomized,
placebo-controlled clinical trials of aspirin, involving a total of
10,703 post-myocardial infarction patients. Canner (1987) later investigated
potential heterogeneity between study characteristics as well as their
reported estimates. The included studies' abbreviations are:
</p>

<table>
<tr>
<td style="text-align: left;">
    UK-1   </td>
<td style="text-align: left;">  first United Kingdom trial </td>
</tr>
<tr>
<td style="text-align: left;">
    CDPA   </td>
<td style="text-align: left;">  Coronary Drug Project Aspirin trial </td>
</tr>
<tr>
<td style="text-align: left;">
    GAMS   </td>
<td style="text-align: left;">  German-Austrian Multicentre Study</td>
</tr>
<tr>
<td style="text-align: left;">
    UK-2   </td>
<td style="text-align: left;">  second United Kingdom trial </td>
</tr>
<tr>
<td style="text-align: left;">
    PARIS  </td>
<td style="text-align: left;">  Persantine-Aspirin Reinfarction Study </td>
</tr>
<tr>
<td style="text-align: left;">
    AMIS   </td>
<td style="text-align: left;">  Aspirin Myocardial Infarction Study
  </td>
</tr>
</table>
<h3>Source</h3>

<p>P.L. Canner. An overview of six clinical trials of aspirin
in coronary heart disease.
<em>Statistics in Medicine</em>, <b>6</b>(3):255-263, 1987.
<a href="https://doi.org/10.1002/sim.4780060310">doi:10.1002/sim.4780060310</a>
</p>


<h3>References</h3>

<p>R. Peto.
Aspirin after myocardial infarction. 
<em>The Lancet</em>, <b>315</b>(8179):1172-1173, 1980.
<a href="https://doi.org/10.1016/S0140-6736%2880%2991626-8">doi:10.1016/S0140-6736(80)91626-8</a>.
</p>
<p>P.C. Elwood, A.L. Cochrane, M.L.Burr, P.M. Sweetnam, G. Williams,
E. Welsby, S.J. Hughes, R. Renton.
A randomized controlled trial of acetyl salicylic acid in the
secondary prevention of mortality from myocardial infarction. 
<em>British Medical Journal</em>, <b>1</b>(5905):436-440, 1974.
<a href="https://doi.org/10.1136/bmj.1.5905.436">doi:10.1136/bmj.1.5905.436</a>.
</p>
<p>The Coronary Drug Project Research Group.
Aspirin in coronary heart disease.
<em>Journal of Chronic Diseases</em>, <b>29</b>(10):625-642, 1976.
<a href="https://doi.org/10.1016/0021-9681%2876%2990020-5">doi:10.1016/0021-9681(76)90020-5</a>.
</p>
<p>K. Breddin, D. Loew, K. Lechner, K. Ueberla, E. Walter.
Secondary prevention of myocardial infarction: a comparison of
acetylsalicylic acid, placebo and phenprocoumon.
<em>Haemostasis</em>, <b>9</b>(6):325-344, 1980.
<a href="https://doi.org/10.1159/000214375">doi:10.1159/000214375</a>.
</p>
<p>P.C. Elwood, P.M. Sweetnam.
Aspirin and secondary mortality after myocardial infarction.
<em>The Lancet</em>, <b>314</b>(8156):1313-1315, 1979.
<a href="https://doi.org/10.1016/S0140-6736%2879%2992808-3">doi:10.1016/S0140-6736(79)92808-3</a>.
</p>
<p>Aspirin Myocardial Infarction Study Research Group.
A randomized, controlled trial of aspirin in persons recovered from
myocardial infarction.
<em>Journal of the American Medical Association</em>,
<b>243</b>(7):661-669, 1980.
<a href="https://doi.org/10.1001/jama.1980.03300330019023">doi:10.1001/jama.1980.03300330019023</a>.
</p>
<p>The Persantine-Aspirin Reinfarction Study Research Group.
Persantine and aspirin in coronary heart disease.
<em>Circulation</em>, <b>62</b>(3):449-461, 1980.
<a href="https://doi.org/10.1161/01.CIR.62.3.449">doi:10.1161/01.CIR.62.3.449</a>.
</p>


<h3>Examples</h3>

<pre><code class="language-R">data("Peto1980")
## Not run: 
# compute effect sizes (log odds ratios) from count data
# (using "metafor" package's "escalc()" function):
require("metafor")
peto.es &lt;- escalc(measure="OR",
                  ai=treat.events,   n1i=treat.cases,
                  ci=control.events, n2i=control.cases,
                  slab=publication, data=Peto1980)
print(peto.es)

# check sensitivity to different prior choices:
peto.ma01 &lt;- bayesmeta(peto.es)
peto.ma02 &lt;- bayesmeta(peto.es, tau.prior=function(t){dhalfnormal(t, scale=1)})
 
par(mfrow=c(2,1))
  plot(peto.ma01, which=4, prior=TRUE, taulim=c(0,1), main="uniform prior")
  plot(peto.ma02, which=4, prior=TRUE, taulim=c(0,1), main="half-normal prior")
par(mfrow=c(1,1))

# compare heterogeneity (tau) estimates:
print(rbind("uniform"    =peto.ma01$summary[,"tau"],
            "half-normal"=peto.ma02$summary[,"tau"]))

# compare effect (mu) estimates:
print(rbind("uniform"    =peto.ma01$summary[,"mu"],
            "half-normal"=peto.ma02$summary[,"mu"]))

summary(peto.ma02)
forestplot(peto.ma02)
plot(peto.ma02)

## End(Not run)
</code></pre>


</div>